SCHEMBL16246264

SCHEMBL16246264

Cc1c(S(=O)(=O)N2CCOCC2)sc(Nc2ccccc2F)c1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.48
▸ KMT2A Q03164 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ALDH1A1 P00352 7/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 4/20 0.42
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CREBBP Q92793 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16246265 0.85 MAPT (0.56) POLBKMT2AALDH1A1LMNAMAPT
SCHEMBL16387392 0.78 FLT3 (0.51) POLBKMT2AALDH1A1MAPTTP53
SCHEMBL16263888 0.77 CNR2 (0.51) KMT2AALDH1A1MAPTTP53TSHR
SCHEMBL16263777 0.75 CNR2 (0.51) KMT2AALDH1A1MAPTTP53TSHR
SCHEMBL16246529 0.72 MAPT (0.45) KMT2AL3MBTL1ALDH1A1LMNAMAPT
SCHEMBL28157400 0.68 MAPT (0.60) POLBKMT2AALDH1A1MAPTTP53
SCHEMBL16246474 0.65 MAPT (0.59) POLBKMT2AALDH1A1LMNAMAPT
SCHEMBL28157299 0.63 MAPT (0.66) POLBKMT2AALDH1A1MAPTTP53
SCHEMBL16088763 0.63 MAPT (0.62) POLBKMT2AALDH1A1LMNAMAPT
SCHEMBL3343329 0.62 PKM (0.58) POLBKMT2AL3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS Galapagos NV (BE) 2016-03-16 — — EP disclosed
WO-2014180562-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2014-11-13 — — WO disclosed
Send feedback